BessisM. (1949). The use of replacement transfusion in diseases other than haemolytic disease of the newborn. Blood, 4, 324.
2.
BrandenburgR. A.SmithH. L. (1951). Sulphaemoglobinaemia: A study of 62 clinical cases. Amer. Heart J., 42, 582.
3.
BrodieB.AxelrodJ. (1949). The fate of acetophenetidin (phenacetin) in man and methods for the estimation of acetophenetidin and its metabolites in biological material. J. Pharm. Exp. Ther., 97, 58.
4.
CampbellD.MorganT. N. (1939). Cyanosis caused by sulphonamide compounds. Lancet, 2, 123.
5.
DiscombeG. (1937). Sulphaemoglobinaemia following sulphanilamide treatment. Lancet, 1, 626.
6.
HoustonI. B.BarlowA. M. (1959). Acute haemolytic anaemia and methaemoglobinaemia produced by phenacetin. Lancet, 2, 1062.
7.
McCutcheonA. D. (1960). Sulphaemoglobinaemia and glutathione. Lancet, 2, 240.
8.
McGibbonB. H.LoughridgeL. W.HouribaneD. O'B.BoydD. W. (1960). Autoimmune haemolytic anaemia and acute renal failure due to phenacetin and p-aminosalicylic acid. Lancet, 1, 7.
9.
SchnitzerB.SmithE. B. (1966). Effects of the metabolites of phenacetin on the rat. Arch. Path., 81, 264.
10.
SelwynJ. G. (1955). Heinz bodies in red cells after splenectomy and after phenacetin administration. Brit. J. Haemat., 1, 173.
11.
SnapperI. (1922). Autotoxic sulphaemoglobinaemia. Ned. T. Geneesk., 1, 2520.
12.
WynnR. M. (1963). The obstetric significance of the factors affecting the metabolism of bilirubin, with particular reference to the role of Vit. K. Obstet. gynec. Surv., 18, 333.
